Skip to main
NBY
NBY logo

NovaBay Pharmaceuticals (NBY)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy NovaBay Pharmaceuticals (NBY) Stock

About NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Market cap$114.67M
Today's volume22.25K
Revenue (TTM)$2.83M
Avg. daily volume3.99M
EBITDA (TTM)-$6.83M
Open$0.98
Price / earnings ratio-0.61x
Today's range$0.92 - $0.98
Debt / equity59.36x
52 week range$0.3 - $2.93
5 year debt / equity-99.6x
Beta (LTM)0.49x
Interest coverage-5.5x
Dividend & yield$0.00 (0.00%)
Current ratio1.98x
Ex-dividend date
Next earningsApr 1, 2026
Dividend payable date

Frequently Asked Questions (FAQ)

As of Nov 24, 2025, the market cap for NBY stock is $114.67M

The current P/E ratio for NBY stock is -0.61

The 52-week high for NBY stock is $2.93. The current NBY stock price $undefined is 100.00% below its 52-week high

The 52-week low for NBY stock is $0.30. The current NBY stock price $undefined has increased 100.00% from its 52-week low

No, the NBY stock does not pay dividends to its shareholders

How to buy NBY stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NBY stock

    Navigate to the Explore page. Then, type NBY into the search bar. When you see NBY stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NBY stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

NovaBay Pharmaceuticals Stock Earnings

The value each NBY share was expected to gain vs. the value that each NBY share actually gained.

NovaBay Pharmaceuticals (NBY) reported Q3 2025 earnings per share (EPS) of -$0.23, missing estimates of -$0.08 by 187.50%. In the same quarter last year, NovaBay Pharmaceuticals's earnings per share (EPS) was -$0.60. NovaBay Pharmaceuticals is expected to release next earnings on 04/01/2026, with an earnings per share (EPS) estimate of -$0.08.

Buy NovaBay Pharmaceuticals (NBY) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.